🇺🇸 FDA
Patent

US 9814771

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 9814771 (Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K2039/552